Noninvasive Test for Colon Cancer Screening Offered as an Alternative to Colonoscopy for Screening

“The only real cure for cancer is finding it early,” said Padma Sundar, vice president of strategy and market access at CellMax Life, in an interview with MD+DI. In terms of colorectal cancer, she said it takes a long time for an adenoma to develop into cancer, so early detection of these adenomas can be lifesaving. But colonoscopy, although the gold standard of adenoma and colon cancer detection, has issues with patient compliance. There are about 125 million Americans, 45 years old and older, who are advised to have routine screening for colorectal cancer. “Unfortunately, 50 million of these 125 million Americans have never undergone screening and that includes about 20 million people between the ages of 45-50 who have been added to the pool because of the rising incidence of colorectal in younger adults,” Sundar said. “There are another 30 million who have already been recommended to have screening who are over 50 years old, but they just don’t want to use colonoscopy because it’s not convenient. It’s invasive, and it involves bowel prep,” she explained. Clearly, there is a need for accurate noninvasive screening for adenoma and colorectal cancer. CellMax Life has developed a patented platform called CMx that captures precancerous and cancer cells that are shed into the blood by tumors. The...
Source: MDDI - Category: Medical Devices Authors: Tags: IVD Source Type: news